Review
ChimeriVax-West Nile vaccine
Affiliations
- PMID: 17932814
Item in Clipboard
Review
ChimeriVax-West Nile vaccine
Curr Opin Mol Ther.
2007 Oct.
Abstract
Acambis (formerly Peptide Therapeutics) is developing ChimeriVax-West Nile, a recombinant live-attenuated vaccine which incorporates their ChimeriVax platform technology, for the potential prevention of West Nile virus infection [373463], [328969]. A phase II clinical trial to assess the safety, tolerability and immunogenicity of different doses of ChimeriVax-West Nile is underway [642090], [775386].
Similar articles
-
Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.Equine Vet J. 2007 Nov;39(6):486-90. doi: 10.2746/042516407X214473. Equine Vet J. 2007. PMID: 18065304
-
Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.Equine Vet J. 2007 Nov;39(6):491-7. doi: 10.2746/042516407X217416. Equine Vet J. 2007. PMID: 18065305
-
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Vaccine. 2010. PMID: 19808029 Review.
-
Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.Expert Rev Vaccines. 2007 Apr;6(2):183-91. doi: 10.1586/14760584.6.2.183. Expert Rev Vaccines. 2007. PMID: 17408368 Review.
-
The evolving means of protecting horses against West Nile infection through immunisation.Equine Vet J. 2007 Nov;39(6):484-5. doi: 10.2746/042516407X247116. Equine Vet J. 2007. PMID: 18065303 Review. No abstract available.
Cited by
-
Zika Virus: Medical Countermeasure Development Challenges.PLoS Negl Trop Dis. 2016 Mar 2;10(3):e0004530. doi: 10.1371/journal.pntd.0004530. eCollection 2016 Mar. PLoS Negl Trop Dis. 2016. PMID: 26934531 Free PMC article. Review.
-
Bioinformatics in new generation flavivirus vaccines.J Biomed Biotechnol. 2010;2010:864029. doi: 10.1155/2010/864029. Epub 2010 May 10. J Biomed Biotechnol. 2010. PMID: 20467477 Free PMC article.
-
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.Virol J. 2010 May 12;7:95. doi: 10.1186/1743-422X-7-95. Virol J. 2010. PMID: 20462412 Free PMC article.
-
Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.Immunology. 2010 Aug;130(4):527-35. doi: 10.1111/j.1365-2567.2010.03251.x. Epub 2010 Mar 16. Immunology. 2010. PMID: 20331473 Free PMC article.
-
Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.Vaccine. 2009 Feb 5;27(6):893-903. doi: 10.1016/j.vaccine.2008.11.087. Epub 2008 Dec 12. Vaccine. 2009. PMID: 19070640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical